{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:10:19Z","timestamp":1769314219309,"version":"3.49.0"},"reference-count":0,"publisher":"Codon Publications","issue":"2","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["jkcvhl"],"abstract":"<jats:p>Hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC) associated renal cell carcinoma (RCC) is an aggressive form of type 2 papillary RCC caused by deficiency of the fumarate hydratase gene. For patients with metastatic disease, no standard treatment has been established with dismal prognosis. We report a case of metastatic HLRCC-associated RCC in a 65-year-old Japanese male whose clinical features mimicked advanced renal pelvic cancer. A durable response was achieved with a sequence of axitinib and nivolumab after cytoreductive and diagnostic nephrectomy. Their potential therapeutic roles in the management of metastatic HLRCC-associated RCC have been discussed based on its molecular and biological backgrounds.<\/jats:p>","DOI":"10.15586\/jkcvhl.2020.148","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T16:35:18Z","timestamp":1595522118000},"page":"6-10","source":"Crossref","is-referenced-by-count":13,"title":["A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy"],"prefix":"10.15586","volume":"7","author":[{"given":"Ichiro","family":"Yonese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Kamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6228","published-online":{"date-parts":[[2020,7,20]]},"container-title":["Journal of Kidney Cancer and VHL"],"original-title":[],"link":[{"URL":"https:\/\/jkcvhl.com\/index.php\/jkcvhl\/article\/download\/148\/271","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jkcvhl.com\/index.php\/jkcvhl\/article\/download\/148\/272","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jkcvhl.com\/index.php\/jkcvhl\/article\/download\/148\/273","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jkcvhl.com\/index.php\/jkcvhl\/article\/download\/148\/271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T11:24:07Z","timestamp":1633951447000},"score":1,"resource":{"primary":{"URL":"https:\/\/jkcvhl.com\/index.php\/jkcvhl\/article\/view\/148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6,9]]}},"URL":"https:\/\/doi.org\/10.15586\/jkcvhl.2020.148","relation":{},"ISSN":["2203-5826"],"issn-type":[{"value":"2203-5826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]}}}